Dreams into reality: The ground breaking journey of Sasidhar Duggineni

With his passion for research, commitment to compliance, and drive for continuous improvement, Sasidhar continues to drive positive change, ensuring that dreams turn into reality for patients and healthcare professionals alike

The life science industry encompasses a broad range of scientific disciplines, including pharmaceuticals, biotechnology, medical devices, diagnostics, and healthcare services. It is a sector dedicated to the advancement of knowledge and technologies that improve human health and well-being. The industry plays a pivotal role in the development, testing, and commercialisation of innovative drugs, therapies, and medical technologies.

This industry became particularly integral during the pandemic. And during that time, few individuals rose to prominence as innovators and thought leaders, people who saw the horrors of Covid-19 and resolved to attack each challenge head-on to save lives all over the world.

One of these noteworthy innovators is Sasidhar Duggineni.

His is a name that resonates with achievement and excellence in the field of life science. With over 12 years of experience in clinical research organisations and big pharma companies, Duggineni has made significant contributions to the industry and public health. His journey is a testament to the power of determination, hard work, and a passion for making a difference in the healthcare sector.

Duggineni's expertise lies in the space of clinical data integrity, and his research work in this space has garnered international attention and recognition. He has multiple research papers published in reputed journals like ISACA and the Open Journal of Optimisation, and his research is making a huge impact in the field. Duggineni has developed a new improvised framework of data integrity as code (DIaC). Data integrity as Code (DIaC) is increasingly finding its way as a standard in code compiling and code reviews, radically changing the way clinical data integrity is achieved.

"My industry was called upon for previously unheard-of demands during Covid-19," says Duggineni. "Research played a crucial role at that time in the success of Covid-19 vaccine trials conducted by our clinical research organisation."

His contributions to these trials have been instrumental in advancing America's healthcare standards and life expectancy. Duggineni's involvement with federally funded research from agencies like NIH showcases his commitment to supporting medical research initiatives that have far-reaching implications.

As an editorial board member of prestigious journals such as the "World Journal of Pharmacy and Pharmaceutical Sciences," "Applied Science and Engineering Journal for Advanced Research," and the "International Multidisciplinary Research Journal," Sasidhar has been actively involved in peer-reviewing high-impact research papers, further contributing to the scientific community.

"I'm currently serving as the compliance manager at a leading clinical research organisation," says Duggineni. "The company has a global presence and a workforce of over 30,000 employees and is a leading provider of clinical research services. The company's commitment to consistent quality, exceptional customer service, and continuous innovation aligns perfectly with my vision."

"I've always had a passion for growth, education, and continuous improvement," Duggineni shares. "This has led to the ability to identify gaps in systems, which has resulted in enhanced capabilities for investigations related to data integrity and privacy breaches. You have to be very meticulous with the analysis and implementation of new technical requirements."

Due to his diligence, systems within the organisation have become fully compatible for performing investigations, thus attracting new business worth millions of dollars. His expertise also extends to auditing technology vendors for virtual clinical trials. His audits have not only qualified technology providers but also led to the implementation of additional compliance and governance controls, resulting in accelerated drug development and earlier market approval for various critical drugs and vaccines.

Sasidhar Duggineni

"Success is seeing dreams turn into reality," Duggineni says. "It's not about the bottom line. It's about making a difference in the world and applying research and technology to the all-encompassing goal of saving lives."

Duggineni's journey is a testament to his unwavering dedication to excellence and making a critical impact with novel contributions to the healthcare industry. With his passion for research, commitment to compliance, and drive for continuous improvement, Sasidhar continues to drive positive change, ensuring that dreams turn into reality for patients and healthcare professionals alike.

Learn more: https://www.linkedin.com/in/sduggineni/

• KT Network